INSMED Inc — Director's Dealing 2022

Jul 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-07-12

Reporting Person: Smith Michael Alexander (General Counsel, Senior VP)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-12	Common Stock	S	941	$23.40	Disposed	50455	Direct

Footnotes

F1: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

F2: Includes 813 shares acquired through the Company's 2018 Employee Stock Purchase Plan.